Delivery Order SPE2DB25D3003-SPE2DB25FPWLY

Award Date 5/29/25
Potential Completion Date 5/30/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,182.92 firm fixed-price contract is for the delivery of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a completion date of May 23, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,341.96, is for the supply of JANUVIA 100 MG TABLET 90S, a drug used to treat type 2 diabetes. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through May 30, 2024. AmerisourceBergen has a larger $999,999,999 IDC with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,502.24, is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product used in the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract has no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The $6,368.56 firm fixed price contract is for the provision of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 2, 2024 and does not include any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,867.08 firm fixed-price contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $18,923.61, is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a period of performance through May 28, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $2,792.76 and a completion date of May 21, 2025. This contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,842.21, is for the delivery of JANUVIA 100 MG TABLET 90S, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of December 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,331.10 firm fixed-price contract is for the delivery of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,134.52, is for the supply of JANUVIA 100 MG TABLET 1000S, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of November 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPWLY
    Delivery Order

This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,544.45 firm fixed-price contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract.

Generated 8/31/25, 1:43 AM